News
2h
Oxford Mail on MSNBusiness at forefront of Covid vaccine trial ceases tradingUse precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
VANCOUVER, BC / ACCESS Newswire / / Onco-Innovations Limited(CBOE CA:ONCO)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly-owned subsidiary, Inka Health ...
A potential $4 billion licensing deal with Vor Bio triggered a slide in RemeGen's stock price. Otsuka obtained a BCMAXCD3 ...
1d
TipRanks on MSNAstraZeneca’s New Study on AZD5492: A Potential Game-Changer for Autoimmune DiseasesAstraZeneca has launched a Phase I clinical study titled An Open-label, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 Followi ...
AstraZeneca has launched a new Global Hub in Bengaluru, investing Rs 166 crore for AI healthcare solutions. This move aims to ...
BlackDoctor Foundation & AstraZeneca unite to fight cancer & lupus. Hear inspiring survivor stories and learn about early ...
This was the ADR's second consecutive day of losses.
AstraZeneca has started the process to improve its cancer treatment capabilities with an addition to its campus in southwest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results